 NEW YORK--BUSINESS WIRE--WaterMill Asset Management Corp. together with its affiliates, WaterMill or we, which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3 of the outstanding shares of Ziopharm Oncology, Inc. NASDAQ: ZIOP Ziopharm or the Company, today announced that Institutional Shareholder Services Inc. ISS, a leading independent proxy voting advisory firm, recommends shareholders vote for boardroom change on th 